Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRDN · against 354 other Healthcare companies of similar size
Ranked #23 of 355 · scores higher than 93% of peers
Bars: peers in each 10-point band of the profitability score44 peers with a profitability score of 90–100, including GRDN · Click a bar to see the companies
Mainly thanks to its return on assets and return on invested capital, which are stronger than most Healthcare peers.
| Metric | GRDN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 336 reported | 40.2% | 6.9% | 95% | 33% | |
| Operating marginHigher is better · 328 reported | 5.8% | 9.0% | 41% | 33% | |
| Return on assetsHigher is better · 338 reported | 14.9% | 2.5% | 95% | 33% | |
| Return on equityHigher is better · 327 reported | 30.4% | 6.1% | 95% | Context only | |
| Gross marginHigher is better · 364 reported | 21.6% | 47.6% | 25% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 20 | 2.2B USD | 95 | 78 | |
| 23 | 21.1B HKD (≈$2.7B) | 94 | 67 | |
| 23 | 26.5B CNY (≈$3.7B) | 94 | 69 | |
| 23 | 179.7B INR (≈$2.2B) | 94 | 74 | |
| 23 | 2.6B USD | 94 | 66 | |
| 23 | 2.3B USD | 94 | 67 | |
| 28 | 11.3B CNY (≈$1.6B) | 93 | 76 | |
| 28 | 414.8B INR (≈$5.0B) | 93 | 73 | |
| 28 | 1.5B USD | 93 | 93 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score